| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |